OPKO Health, Inc.
OPKO Health, Inc. (OPK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OPK · as of Jun 8, 2026
Key Statistics
Explore OPKO Health, Inc. Data
opk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 61.5%
The OPK analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $2.87, representing +102.11% upside from the current price of $1.42.
Competitors & Peers
opk competitorsOPK
CTEV
DNTH
LFMD
NKTR
OCSStock Performance
Full HistoryAbout OPKO Health, Inc.
OPKO Health, Inc. a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagn…
what is opko health, inc. · opk stock overview · opko health, inc. company profile · who is opko health, inc. ceo · opk NASDAQ · opko health, inc. headquarters · opko health, inc. business segments
About Stock Overview & Key Data
OPKO Health, Inc. (OPK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 2, 1995. As of the latest trading session, OPK stock price is $1.42, with a market capitalization of $1.1B. The stock has returned +3.99% over the past 12 months and +13.89% year-to-date.
According to 13 Wall Street analysts, the consensus rating for OPKO Health, Inc. stock is Buy, with an average 12-month price target of $2.87. In fiscal year 2025, OPKO Health, Inc. reported revenue of $606.9M and net income of -$225.7M. For detailed data — including OPKO Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, OPKO Health, Inc. (OPK) stock price is $1.42. The stock is traded on NASDAQ under the ticker symbol OPK. The 52-week range is $0.98 – $1.60.